Long-term central IV access in patients with mitochondrial disease

Area of Science:

• Genetics and Medicine
• Mitochondrial Biology
• Gastroenterology

Background:

• Mitochondrial disease stems from genetic alterations affecting mitochondrial function.
• Patients exhibit multisystem involvement, notably gastrointestinal (GI) dysfunction (obstruction, malabsorption).
• Immunosuppression and sepsis risk are common in this vulnerable population.

Purpose of the Study:

• To provide an overview of patients with mitochondrial disease and GI dysfunction.
• To outline a plan for safe and effective central intravenous (IV) access care in this population.
• To emphasize quality-of-life goals in managing this incurable condition.

Main Methods:

• Review of existing literature on mitochondrial disease and GI complications.
• Analysis of care requirements for patients needing long-term central IV access.
• Development of best practices for central IV access in high-acuity home care settings.

Main Results:

• Mitochondrial disease necessitates comprehensive management due to multisystemic effects.
• Central IV access is often critical for hyperalimentation, fluids, and medications.
• Effective central IV care is essential for preventing complications like sepsis and maintaining quality of life.

Conclusions:

• Patients with mitochondrial disease and GI dysfunction present unique care challenges.
• Safe and effective central IV access is paramount for managing these patients.
• A structured approach to central IV care can improve outcomes and quality of life.